Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Carcinoma to the Uterine Cervix”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04973904
What this trial is testing

Toripalimab Combined With Chemotherapy and Bevacizumab as First-Line Treatment in Patients With Advanced Cervical Cancer

Who this might be right for
Cervical Cancer
Peking Union Medical College Hospital 35
Testing effectiveness (Phase 2)Study completedNCT04680988
What this trial is testing

SHR-1210± SHR-1020 Versus Chemotherapy in Patients With Recurrent or Metastatic Cervical Cancer

Who this might be right for
Recurrent or Metastatic Cervical Cancer
Jiangsu HengRui Medicine Co., Ltd. 194
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07763496
What this trial is testing

Relacorilant and Nab-Paclitaxel in Recurrent or Metastatic Cervical Cancer

Who this might be right for
Recurrent or Metastatic Cervical Cancer
ARCAGY/ GINECO GROUP 63
Not applicableUnknownNCT03029013
What this trial is testing

Apatinib and Chemotherapy Sequential Treatment With Cervical Cancer

Who this might be right for
Cervical Cancer
Third Military Medical University 30
Early research (Phase 1)Ended earlyNCT03277482
What this trial is testing

Durvalumab, Tremelimumab + Radiotherapy in Gynecologic Cancer

Who this might be right for
Recurrent Gynecological CancerMetastatic Cervical CancerMetastatic Ovarian Cancer+8 more
Dana-Farber Cancer Institute 16
Testing effectiveness (Phase 2)Ended earlyNCT03367871
What this trial is testing

Combination Pembrolizumab, Chemotherapy and Bevacizumab in Patients With Cervical Cancer

Who this might be right for
Cervical Cancer
University of Miami 17
Testing effectiveness (Phase 2)UnknownNCT05606263
What this trial is testing

Efficacy and Safety of Caldonirimab Plus Nimotuzumab for Recurrent or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
Xi'an Jiaotong University 55
Large-scale testing (Phase 3)Looking for participantsNCT06459687
What this trial is testing

Phase III Study of Socazolimab as First-Line Treatment in Persistent, Recurrent, or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
Lee's Pharmaceutical Limited 440
Large-scale testing (Phase 3)Active Not RecruitingNCT04982237
What this trial is testing

AK104 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
Akeso 445
Testing effectiveness (Phase 2)UnknownNCT03912402
What this trial is testing

Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy and Bevacizumab in Patients With Recurrent, Persistent or Metastatic Cervical Cancer (CAESURA)

Who this might be right for
Cervical CancerCervical Cancer MetastaticCervical Cancer Recurrent
Biocad 49
Not applicableEnded earlyNCT03786107
What this trial is testing

HER-Seq: A Blood-based Screening Study to Identify Patients With HER2 Mutations for Enrollment Into Clinical Research Studies of Neratinib

Who this might be right for
Hormone Receptor-Positive, HER2-Negative Metastatic Breast CancerMetastatic Cervical Cancer
Puma Biotechnology, Inc. 1,583
Early research (Phase 1)UnknownNCT05475847
What this trial is testing

Study of C-TIL052A Cell Therapy in Advanced Cervical Cancer

Who this might be right for
Cervical Cancer
Fudan University 20
Large-scale testing (Phase 3)Looking for participantsNCT07216703
What this trial is testing

A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)

Who this might be right for
Cervical Cancer
Merck Sharp & Dohme LLC 1,023
Not applicableActive Not RecruitingNCT04266886
What this trial is testing

Self-Hypnosis for the Enhanced Recovery After Surgery in Patients With Gynecologic Cancer

Who this might be right for
Malignant Female Reproductive System NeoplasmRecurrent Malignant Female Reproductive System NeoplasmMetastatic Cervical Cancer
M.D. Anderson Cancer Center 152
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06039891
What this trial is testing

Nimotuzumab Plus Tislelizumab for Recurrent and Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
Peking Union Medical College Hospital 55
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07035808
What this trial is testing

A Single Arm, Phase II Multicenter Clinical Trial to Evaluate the Efficacy and Safety of the Combination Therapy of Iparomlimab and Tuvonralima b and Chemotherapy ± Bevacizumab Induction Therapy Followed by Concurrent Chemoradiotherapy in Patients With Advanced Cervical Cancer .

Who this might be right for
Cervical Cancer Stage IVACervical Cancer Metastatic
Zhejiang Cancer Hospital 46
Testing effectiveness (Phase 2)Active Not RecruitingNCT04652076
What this trial is testing

GYNecological Cancers Treated with NETrin MAbs in Combination with Chemotherapy and /or Pembrolizumab

Who this might be right for
Endometrial CarcinomaCervix Carcinoma
NETRIS Pharma 240
Large-scale testing (Phase 3)Not Yet RecruitingNCT07797153
What this trial is testing

JSKN033 Versus Investigator's Choice of Chemotherapy in Recurrent or Metastatic Cervical Cancer

Who this might be right for
Recurrent or Metastatic Cervical Cancer
Jiangsu Alphamab Biopharmaceuticals Co., Ltd 368
Testing effectiveness (Phase 2)Ended earlyNCT04651127
What this trial is testing

Anti-PD-1 Antibody Combined With Histone Deacetylase Inhibitor in Patients With Advanced Cervical Cancer

Who this might be right for
Cervical CancerCervix CancerCervix Neoplasm
Sun Yat-sen University 5
Testing effectiveness (Phase 2)Study completedNCT03241173
What this trial is testing

A Study Exploring the Safety and Efficacy of INCAGN01949 in Combination With Immune Therapies in Advanced or Metastatic Malignancies

Who this might be right for
Advanced Malignancies
Incyte Biosciences International Sàrl 52
Next Page